Tamoxifen: Five versus ten years - Is the end in sight?

被引：11

作者：

Abrams, JA ^{[1
]}

机构：

[1] NCI, Canc Therapy Evaluat Program, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2001年 / 93卷 / 09期

关键词：

D O I：

10.1093/jnci/93.9.662

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：662 / 664

页数：3

共 22 条

[1] ABE O, 1992, LANCET, V339, P71
[2] [Anonymous], 1985, JAMA, V254, P3461
[3] [Anonymous], BREAST CANC RES TREA
[4] Carlson R W, 1997, Semin Oncol, V24, pS1
[5] Clarke M, 1998, LANCET, V351, P1451
[6] Tamoxifen adjuvant treatment duration in early breast cancer:: Initial results of a randomized study comparing short-term treatment with long-term treatment
Delozier, T
Spielmann, M
Macé-Lesec'h, J
Janvier, M
Hill, C
Asselain, B
Julien, JP
Weber, B
Mauriac, L
Petit, JC
Kerbrat, P
Malhaire, JP
Vennin, P
Leduc, B
Namer, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3507 - 3512
[7] Early stopping of a clinical trial when there is evidence of no treatment benefit: Protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project
Dignam, JJ
Bryant, J
Wieand, HS
Fisher, B
Wolmark, N
[J]. CONTROLLED CLINICAL TRIALS, 1998, 19 (06): : 575 - 588
[8] Earl H, 1997, Clin Oncol (R Coll Radiol), V9, P141, DOI 10.1016/S0936-6555(97)80067-2
[9] Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial
Fisher, B
Dignam, J
Bryant, J
Wolmark, N
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09): : 684 - 690
[10] Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors
Fisher, B
Dignam, J
Bryant, J
DeCillis, A
Wickerham, DL
Wolmark, N
Costantino, J
Redmond, C
Fisher, ER
Bowman, DM
Deschenes, L
Dimitrov, NV
Margolese, RG
Robidoux, A
Shibata, H
Terz, J
Paterson, AHG
Feldman, MI
Farrar, W
Evans, J
Lickley, HL
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21): : 1529 - 1542

← 1 2 3 →